
372. A First-in-Human Clinical Trial of Adoptive Therapy Using CD19-Specific Chimeric Antigen Receptor Re-Directed T Cells for Recurrent/Refractory Follicular Lymphoma
Volume:
15
Langue:
english
Journal:
Molecular Therapy
DOI:
10.1016/s1525-0016(16)44578-8
Date:
May, 2007
Fichier:
PDF, 546 KB
english, 2007